Treatment changes in patients with psoriasis on etanercept or adalimumab: a retrospective chart review.
CONCLUSION: Although biologics are considered the gold standard for psoriasis, clinicians should still take individual variations in response and preferences into account.
PMID: 29448850 [PubMed - as supplied by publisher]
Source: Journal of Dermatological Treatment - Category: Dermatology Tags: J Dermatolog Treat Source Type: research